Literature DB >> 9351886

PTHrP(107-111) inhibits in vivo resorption that was stimulated by PTHrP(1-34) when applied intermittently to neonatal mice.

S Rihani-Basharat1, D Lewinson.   

Abstract

Stimulated resorption by PTH(1-34) and PTHrP(1-34) was studied in a neonatal mouse model by injecting a relatively high dose (0.2 microgram/g BW) of the peptides for 6 or 16 consecutive daily injections. 3H-Tetracycline was applied once, before the beginning of the injection period. Only PTHrP(1-34) increased resorption as revealed by decreased radioactivity remaining in the tibia when compared with vehicle-treated mice. This activity was related to increased numbers of mature osteoclasts in the metaphysis of the young bones. PTHrP(107-111) completely aborted the stimulated resorption when applied simultaneously with PTHrP(1-34).

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9351886     DOI: 10.1007/s002239900359

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  6 in total

1.  Synchrotron ultraviolet microspectroscopy on rat cortical bone: involvement of tyrosine and tryptophan in the osteocyte and its environment.

Authors:  Stéphane Pallu; Gael Y Rochefort; Christelle Jaffre; Matthieu Refregiers; Delphine B Maurel; Delphine Benaitreau; Eric Lespessailles; Frédéric Jamme; Christine Chappard; Claude-Laurent Benhamou
Journal:  PLoS One       Date:  2012-08-28       Impact factor: 3.240

2.  Treatment with N- and C-terminal peptides of parathyroid hormone-related protein partly compensate the skeletal abnormalities in IGF-I deficient mice.

Authors:  Lourdes Rodríguez-de la Rosa; Ana López-Herradón; Sergio Portal-Núñez; Silvia Murillo-Cuesta; Daniel Lozano; Rafael Cediel; Isabel Varela-Nieto; Pedro Esbrit
Journal:  PLoS One       Date:  2014-02-04       Impact factor: 3.240

3.  Nanoparticles to Knockdown Osteoporosis-Related Gene and Promote Osteogenic Marker Expression for Osteoporosis Treatment.

Authors:  Patricia Mora-Raimundo; Daniel Lozano; Miguel Manzano; María Vallet-Regí
Journal:  ACS Nano       Date:  2019-05-13       Impact factor: 15.881

Review 4.  Proteolytic Regulation of Parathyroid Hormone-Related Protein: Functional Implications for Skeletal Malignancy.

Authors:  Jeremy S Frieling; Conor C Lynch
Journal:  Int J Mol Sci       Date:  2019-06-08       Impact factor: 5.923

5.  Osteostatin Inhibits M-CSF+RANKL-Induced Human Osteoclast Differentiation by Modulating NFATc1.

Authors:  Lidia Ibáñez; Josep Nácher-Juan; María Carmen Terencio; María Luisa Ferrándiz; María José Alcaraz
Journal:  Int J Mol Sci       Date:  2022-08-01       Impact factor: 6.208

6.  Osteogenic Effect of ZnO-Mesoporous Glasses Loaded with Osteostatin.

Authors:  Rebeca Pérez; Sandra Sanchez-Salcedo; Daniel Lozano; Clara Heras; Pedro Esbrit; María Vallet-Regí; Antonio J Salinas
Journal:  Nanomaterials (Basel)       Date:  2018-08-04       Impact factor: 5.076

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.